• 1. Alumina grafted SBA-15 sustainable bifunctional catalysts for direct cross-coupling of benzylic alcohols to diarylmethanes?
  Chandran Rajendran,Govindaswamy Satishkumar,Charlotte Lang,Eric M. Gaigneaux Catal. Sci. Technol., 2020,10, 2583-2592
• 2. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 3. An all-solid-state imprinted polymer-based potentiometric sensor for determination of bisphenol S?
  Rongning Liang,Tanji Yin,Ruiqing Yao,Wei Qin RSC Adv., 2016,6, 73308-73312
• 4. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 5. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383

Professional Introduction to 1H-INDOLE-1-ACETIC ACID, 4-AMINO-, ETHYL ESTER (CAS No. 85696-96-4)

1H-INDOLE-1-ACETIC ACID, 4-AMINO-, ETHYL ESTER, with the CAS number 85696-96-4, is a significant compound in the field of pharmaceutical chemistry and bioorganic synthesis. This ester derivative of indole, characterized by an amino group at the 4-position and an ethyl ester at the 1-position, has garnered attention due to its structural versatility and potential biological activity. The indole core is a privileged scaffold in medicinal chemistry, known for its presence in numerous bioactive natural products and drug candidates. The introduction of functional groups such as an amino group and an ester moiety further enhances its utility in synthetic chemistry and drug development.

The compound’s chemical structure consists of a benzene ring fused to a pyrrole ring, with specific substitutions that dictate its reactivity and interactions with biological targets. The amino group at the 4-position of the indole ring introduces basicity and potential hydrogen bonding capabilities, which are crucial for binding to biological receptors. Additionally, the ethyl ester functionality at the 1-position provides a site for further derivatization, enabling the synthesis of more complex molecules through hydrolysis or transesterification reactions.

In recent years, there has been growing interest in indole derivatives as pharmacological agents due to their diverse biological activities. Studies have demonstrated that modifications at various positions of the indole ring can modulate interactions with enzymes, receptors, and other cellular targets. Specifically, derivatives with amino substituents have shown promise in inhibiting enzymes involved in inflammatory pathways, making them attractive candidates for therapeutic applications.

One of the most compelling aspects of 1H-INDOLE-1-ACETIC ACID, 4-AMINO-, ETHYL ESTER is its potential as a precursor in the synthesis of more complex bioactive molecules. Researchers have leveraged this compound to develop novel scaffolds for drug discovery programs. For instance, its structural framework can be modified to create analogs with enhanced binding affinity or selectivity for specific biological targets. The versatility of this compound allows chemists to explore various synthetic pathways, including nucleophilic substitution reactions at the amino or ester positions.

The pharmaceutical industry has been particularly interested in indole derivatives due to their role in treating a wide range of diseases. Recent studies have highlighted the therapeutic potential of indole-based compounds in oncology, neurology, and infectious diseases. For example, derivatives of indole have been investigated for their ability to modulate immune responses and inhibit tumor growth. The presence of both an amino group and an ester moiety in 1H-INDOLE-1-ACETIC ACID, 4-AMINO-, ETHYL ESTER makes it a valuable building block for designing such therapeutics.

Synthetic methodologies for preparing 1H-INDOLE-1-ACETIC ACID, 4-AMINO-, ETHYL ESTER have been refined over time to achieve high yields and purity. Common approaches include nucleophilic aromatic substitution (SNAr) reactions on halogenated indole precursors followed by esterification. Advances in catalytic systems have further improved the efficiency of these synthetic routes, allowing for scalable production. Additionally, green chemistry principles have been incorporated into these processes to minimize waste and reduce environmental impact.

The biological evaluation of 1H-INDOLE-1-ACETIC ACID, 4-AMINO-, ETHYL ESTER has revealed intriguing properties that warrant further investigation. In vitro assays have shown that this compound exhibits moderate activity against certain enzymes and cellular lines relevant to human health conditions. These preliminary findings suggest that further optimization could lead to the development of novel therapeutic agents with improved efficacy and reduced side effects.

Future research directions may focus on exploring new synthetic strategies to diversify the structural landscape of indole derivatives derived from this compound. Additionally, computational modeling techniques can be employed to predict binding modes and optimize lead structures before experimental validation. Collaborative efforts between synthetic chemists and biologists will be essential in translating these findings into tangible therapeutic benefits.

In conclusion,1H-INDOLE-1-ACETIC ACID, 4-AMINO-, ETHYL ESTER (CAS No. 85696-96-4) represents a promising intermediate in pharmaceutical research due to its versatile structure and potential biological activity. Its role as a building block for more complex molecules underscores its importance in drug discovery programs targeting various diseases. As synthetic methodologies continue to evolve and our understanding of biological systems deepens,this compound is poised to contribute significantly to advancements in medicinal chemistry.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)